Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Milestone Pharmaceuticals Inc is a biotechnology business based in the US. Milestone Pharmaceuticals shares (MIST) are listed on the NASDAQ and all prices are listed in US Dollars. Milestone Pharmaceuticals employs 28 staff and has a market cap (total outstanding shares value) of 0.00.
|Latest market close||$6.05|
|52-week range||$5.09 - $10.45|
|50-day moving average||$5.63|
|200-day moving average||$6.38|
|Wall St. target price||$13.80|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-10.84|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-07-15)||N/A|
|1 month (2021-06-25)||2.72%|
|3 months (2021-04-26)||2.37%|
|6 months (2021-01-22)||N/A|
|1 year (2020-07-22)||N/A|
|2 years (2019-07-22)||N/A|
|3 years (2018-07-22)||N/A|
|5 years (2016-07-22)||N/A|
|Gross profit TTM||$0|
|Return on assets TTM||-23.88%|
|Return on equity TTM||-39.84%|
|Market capitalisation||$167.1 million|
TTM: trailing 12 months
There are currently 230,828 Milestone Pharmaceuticals shares held short by investors – that's known as Milestone Pharmaceuticals's "short interest". This figure is 30.5% down from 332,153 last month.
There are a few different ways that this level of interest in shorting Milestone Pharmaceuticals shares can be evaluated.
Milestone Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Milestone Pharmaceuticals shares currently shorted divided by the average quantity of Milestone Pharmaceuticals shares traded daily (recently around 69317.717717718). Milestone Pharmaceuticals's SIR currently stands at 3.33. In other words for every 100,000 Milestone Pharmaceuticals shares traded daily on the market, roughly 3330 shares are currently held short.
However Milestone Pharmaceuticals's short interest can also be evaluated against the total number of Milestone Pharmaceuticals shares, or, against the total number of tradable Milestone Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Milestone Pharmaceuticals's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Milestone Pharmaceuticals shares in existence, roughly 10 shares are currently held short) or 0.0211% of the tradable shares (for every 100,000 tradable Milestone Pharmaceuticals shares, roughly 21 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Milestone Pharmaceuticals.
Find out more about how you can short Milestone Pharmaceuticals stock.
We're not expecting Milestone Pharmaceuticals to pay a dividend over the next 12 months.
Over the last 12 months, Milestone Pharmaceuticals's shares have ranged in value from as little as $5.09 up to $10.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Milestone Pharmaceuticals's is 3.8954. This would suggest that Milestone Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Milestone Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as in the Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate, and other cardiovascular indications. Milestone Pharmaceuticals Inc. has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil in patients with paroxysmal supraventricular tachycardia and additional cardiovascular conditions in Greater China. The company was incorporated in 2003 and is headquartered in Montréal, Canada. .
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.